News
The FDA has approved Moderna’s new Covid-19 vaccine, though it placed restrictions on its use that the company’s existing ...
This is the web version of STAT’s special newsletter from the annual meeting of the American Society of Oncology. For more ...
The use of Gilead’s Trodelvy and Merck’s Keytruda together could be practice-changing based on the results of a new study ...
Amid ongoing uncertainty around funding for the NIH and what it could mean for U.S. innovation, a top Merck executive ...
Researchers estimated 7.5% more U.S. children would get cavities, affecting 25.4 million additional teeth, if fluoridation ...
Budget documents for Congress provide the most detailed look yet at how the Trump Administration hopes to reshape the ...
Summit Therapeutics said its closely tracked antibody, the first lung cancer drug to beat Merck’s Keytruda in a head-to-head ...
HHS has notified Moderna that it is canceling a nearly $600 million contract for vaccines for flu strains that could trigger ...
Long-term care in the U.S. faces two existential threats: an immigration crackdown and Medicaid cuts
The combined impacts of an immigration crackdown and slashing Medicaid budgets could create an exodus of long-term care ...
The BREAKWATER study enrolled patients with newly diagnosed colon cancer that harbors a mutation called BRAF 600E that makes ...
Little noticed, the ACA reforms in the tax bill could lower enrollment about as much as Medicaid cuts will, and in many of ...
Instead of approving Stealth BioTherapeutics' drug for Barth syndrome, the FDA withheld its endorsement, but decided it may ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results